These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7855218)

  • 81. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
    Wlaź P; Ebert U; Potschka H; Löscher W
    Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
    Nishiyama T
    Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of NMDA receptor antagonists in squirrel monkeys trained to discriminate the competitive NMDA receptor antagonist NPC 12626 from saline.
    Gold LH; Balster RL
    Eur J Pharmacol; 1993 Jan; 230(3):285-92. PubMed ID: 8095022
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
    Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Behavioural and electoencephalographic interactions between haloperidol and PCP/sigma ligands in the rat.
    Sagratella S; Scotti de Carolis A; Pèzzola A; Popoli P
    Psychopharmacology (Berl); 1991; 105(4):485-91. PubMed ID: 1685250
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine.
    Ohmori T; Abekawa T; Muraki A; Koyama T
    Pharmacol Biochem Behav; 1994 Jul; 48(3):587-91. PubMed ID: 7938110
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Development of behavioral sensitization to the cocaine-like fungicide triadimefon is prevented by AMPA, NMDa, DA D1 but not DA D2 receptor antagonists.
    Reeves R; Thiruchelvam M; Cory-Slechta DA
    Toxicol Sci; 2004 May; 79(1):123-36. PubMed ID: 15014204
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
    Willetts J; Clissold DB; Hartman TL; Brandsgaard RR; Hamilton GS; Ferkany JW
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1055-62. PubMed ID: 8099615
    [TBL] [Abstract][Full Text] [Related]  

  • 90. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
    Lauterbach EC
    Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
    Hiramatsu M; Cho AK; Nabeshima T
    Eur J Pharmacol; 1989 Aug; 166(3):359-66. PubMed ID: 2553433
    [TBL] [Abstract][Full Text] [Related]  

  • 92. N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo: Evidence from an NMDA-induced seizure model in rats.
    Witkin JM; Cerne R; Newman AH; Izenwasser S; Smith JL; Tortella FC
    Pharmacol Biochem Behav; 2021 Apr; 203():173154. PubMed ID: 33609599
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task.
    Ylinen A; Pitkänen M; Sirviö J; Hartikainen T; Sivenius J; Koivisto E; Riekkinen PJ
    Eur J Pharmacol; 1995 Feb; 274(1-3):159-65. PubMed ID: 7768268
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.
    Shukla VK; Prasad JA; Lemaire S
    J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene.
    De Sarro GB; De Sarro A
    Neuropharmacology; 1993 Jan; 32(1):51-8. PubMed ID: 8094234
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Behavioural pharmacology of the non-competitive NMDA antagonists dextrorphan and ADCI: relations between locomotor stimulation, anticataleptic potential and forebrain dopamine metabolism.
    Bubser M; Zadow B; Kronthaler UO; Felsheim U; Rückert NG; Schmidt WJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):767-73. PubMed ID: 9205962
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Blockade of the central generator of locomotor rhythm by noncompetitive NMDA receptor antagonists in Drosophila larvae.
    Cattaert D; Birman S
    J Neurobiol; 2001 Jul; 48(1):58-73. PubMed ID: 11391649
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.
    Dall'Olio R; Rimondini R; Gandolfi O
    Psychopharmacology (Berl); 1995 Apr; 118(3):310-5. PubMed ID: 7617824
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat.
    Smith SE; al-Zubaidy ZA; Chapman AG; Meldrum BS
    Epilepsy Res; 1993 Jun; 15(2):101-11. PubMed ID: 8103738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.